Serum Amino Acids in Association with Prevalent and Incident Type 2 Diabetes in A Chinese Population.
Essential amino acids
LC-MS/MS
non-essential amino acids
serum
type 2 diabetes
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
14 Jan 2019
14 Jan 2019
Historique:
received:
20
12
2018
revised:
04
01
2019
accepted:
09
01
2019
entrez:
17
1
2019
pubmed:
17
1
2019
medline:
17
1
2019
Statut:
epublish
Résumé
We aimed to simultaneously examine the associations of both essential and non-essential amino acids with both prevalent and incident type 2 diabetes in a Chinese population. A case-control study was nested within the Singapore Chinese Health Study. Participants included 144 cases with prevalent and 160 cases with incident type 2 diabetes and 304 controls. Cases and controls were individually matched on age, sex, and date of blood collection. Baseline serum levels of 9 essential and 10 non-essential amino acids were measured using liquid chromatography tandem mass spectrometry. We identified that five essential (isoleucine, leucine, lysine, phenylalanine, and valine) and five non-essential (alanine, glutamic acid, glutamine, glycine, and tyrosine) amino acids were associated with the prevalence of type 2 diabetes; four essential (isoleucine, leucine, tryptophan, and valine) and two non-essential (glutamine and tyrosine) amino acids were associated with the incidence of type 2 diabetes. Of these, valine and tyrosine independently led to a significant improvement in risk prediction of incident type 2 diabetes. This study demonstrates that both essential and non-essential amino acids were associated with the risk for prevalent and incident type 2 diabetes, and the findings could aid in diabetes risk assessment in this Chinese population.
Identifiants
pubmed: 30646552
pii: metabo9010014
doi: 10.3390/metabo9010014
pmc: PMC6359471
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : National Medical Research Council
ID : NMRC/CIRG/1354/2013
Organisme : NCI NIH HHS
ID : R01 CA144034
Pays : United States
Organisme : NIH HHS
ID : RO1 CA144034
Pays : United States
Organisme : NIH HHS
ID : UM1 CA182876
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182876
Pays : United States
Références
Biochem Biophys Res Commun. 2002 Dec 20;299(5):693-6
pubmed: 12470633
J Nutr. 2003 Jan;133(1):261S-267S
pubmed: 12514305
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Arch Intern Med. 2008 Nov 24;168(21):2304-10
pubmed: 19029492
Cell Metab. 2009 Apr;9(4):311-26
pubmed: 19356713
Diabetes Care. 2010 Jan;33 Suppl 1:S62-9
pubmed: 20042775
Diabetologia. 2010 Apr;53(4):757-67
pubmed: 20076942
Nat Med. 2011 Apr;17(4):448-53
pubmed: 21423183
Circulation. 2012 May 8;125(18):2222-31
pubmed: 22496159
Diabetes. 2012 Jul;61(7):1895-902
pubmed: 22553379
Cell Metab. 2012 May 2;15(5):606-14
pubmed: 22560213
Diabetes Care. 2012 Aug;35(8):1749-56
pubmed: 22563043
Diabetes. 2013 Feb;62(2):639-48
pubmed: 23043162
Oman Med J. 2012 Jul;27(4):269-73
pubmed: 23071876
Diabetes Care. 2013 Mar;36(3):648-55
pubmed: 23129134
J Clin Endocrinol Metab. 2013 Jun;98(6):E1060-5
pubmed: 23633210
Diabetes. 2013 Dec;62(12):4270-6
pubmed: 23884885
Am J Epidemiol. 2013 Oct 15;178(8):1226-32
pubmed: 24008908
Diabetologia. 2015 May;58(5):968-79
pubmed: 25693751
Physiol Rep. 2015 May;3(5):null
pubmed: 25952934
Sci Rep. 2016 Feb 05;6:20594
pubmed: 26846565
Diabetes. 2016 May;65(5):1424-33
pubmed: 26861782
Diabetes Care. 2016 Apr;39(4):582-8
pubmed: 26895884
Diabetes Care. 2016 May;39(5):833-46
pubmed: 27208380
Nature. 2016 Jul 21;535(7612):376-81
pubmed: 27409811
Int J Epidemiol. 2016 Oct;45(5):1482-1492
pubmed: 27413102
Diabetologia. 2016 Nov;59(11):2349-2359
pubmed: 27514531
Br J Nutr. 2017 Jun;117(11):1523-1530
pubmed: 28721839
J Clin Endocrinol Metab. 2018 Feb 1;103(2):671-680
pubmed: 29267865
Diabetes Care. 1997 Jul;20(7):1183-97
pubmed: 9203460